GeoVax Labs Inc GOVX Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.
This uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Business description A detailed description of the company's operations and business divisions.
Corporate strategy GlobalData's summarization of the company's business strategy.
SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.
Highlights
GeoVax Labs Inc GeoVax is a clinicalstage biotech company that develops human vaccines for human immunodeficiency virus HIV, cancer and other infectious diseases using Modified Vaccinia Ankara VirusLike Particle MVAVLP vaccine platform. The company's vaccine development programs focus on HIV, Zika virus and hemorrhagic fever viruses Ebola, Marburg, Lassa fever and for cancer immunotherapy. Its advanced vaccines under development act against the clade B and clade C subtype of the HIV virus. GeoVax developed its proprietary vaccine technology in collaboration with the U.S. National Institutes of Health NIH, Centers for Disease Control and Prevention CDC, and Emory University. GeoVax is headquartered in Smyrna, Georgia, the US.
GeoVax Labs Inc Key Recent Developments
May 22,2019: GeoVax to conduct partnering meetings during BIO International Convention
May 15,2019: GeoVax to present unique technology at New York Academy of Sciences Vaccine Conference
May 14,2019: GeoVax reports 2019 first quarter financial results and highlights Corporate Development Progress
May 14,2019: GeoVax Labs announces 2019 first quarter financial results
Mar 27,2019: GeoVax reports 2018 yearend financial results
Reasons to Buy
Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.